Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy.

Mitsushige Sugimoto Daiki Hira Masaki MurataTakashi KawaiTomohiro Terada

Published in: Antibiotics (Basel, Switzerland) (2020)

Genotyping for CYP3A4 *1/*22, CYP3A5 *1/*3 and CYP2C19 *1/*2/*3/*17 before vonoprazan-containing eradication treatment may not be useful for predicting clinical outcomes.

Keyphrases

helicobacter pylori
helicobacter pylori infection
genome wide
combination therapy
mesenchymal stem cells
replacement therapy
dna methylation
smoking cessation
genetic diversity
cell therapy